English

BIOSTEM U.S. CORPORATION

EDGAR

Quarterly report (10-Q) · filed 2012-12-17

20 filing records in this dataset, filed from 2009-04-14 to 2012-12-17. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.22 thousand USD

2013 Q3 · USD

Exact inputs and evidence

Revenue: 4218 USD Source

Operating cash flow

-104 thousand USD

2013 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -406554 USD Source
Operating Cash Flow: -302842 USD Source

Cash and cash equivalents: 45.9 thousand USD 2011-08-31 Source
Exact value

45890 USD
Long-term debt including current maturities: Not available
Shares outstanding: 274 thousand shares 2012-11-30 Source
Exact value

273866 shares

Reported share-count change

-99.68% · -84.8 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

85056952 shares · 2011-11-30· Source
273866 shares · 2012-11-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

5.65 thousand USD

2011-12-01 – 2012-11-30

Exact inputs and evidence

Revenue: 94745 USD · 2011-03-01 – 2012-02-29 Source
Revenue: 94058 USD · 2011-03-01 – 2011-11-30 Source
Revenue: 624 USD · 2012-03-01 – 2012-05-31 Source
Revenue: 120 USD · 2012-06-01 – 2012-08-31 Source
Revenue: 4218 USD · 2012-09-01 – 2012-11-30 Source

Net income

-5.21 million USD

2011-12-01 – 2012-11-30

Exact inputs and evidence

Net income: -3337419 USD · 2011-03-01 – 2012-02-29 Source
Net income: -1715751 USD · 2011-03-01 – 2011-11-30 Source
Net income: -883729 USD · 2012-03-01 – 2012-05-31 Source
Net income: -2121348 USD · 2012-06-01 – 2012-08-31 Source
Net income: -579313 USD · 2012-09-01 – 2012-11-30 Source

Operating cash flow

-622 thousand USD

2011-12-01 – 2012-11-30

Exact inputs and evidence

Operating cash flow: -746071 USD · 2011-03-01 – 2012-02-29 Source
Operating cash flow: -530635 USD · 2011-03-01 – 2011-11-30 Source
Operating cash flow: -225221 USD · 2012-03-01 – 2012-05-31 Source
Operating cash flow: -302842 USD · 2012-03-01 – 2012-08-31 Source
Operating cash flow: -225221 USD · 2012-03-01 – 2012-05-31 Source
Operating cash flow: -406554 USD · 2012-03-01 – 2012-11-30 Source
Operating cash flow: -302842 USD · 2012-03-01 – 2012-08-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-12-17.

Financial data available through: 2012-02-29.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2012-02-29
Operating income: 2 of 11 periods available· newest 2011-02-28
Net income: 3 of 11 periods available· newest 2012-02-29
Operating cash flow: 3 of 11 periods available· newest 2012-02-29
capital expenditure: No compatible figures in this window
Total assets: 3 of 11 periods available· newest 2012-02-29
Total liabilities: 3 of 11 periods available· newest 2012-02-29
Current assets: 3 of 11 periods available· newest 2012-02-29
Current liabilities: 3 of 11 periods available· newest 2012-02-29
Cash and cash equivalents: 2 of 11 periods available· newest 2011-02-28
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2012-02-29

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+544.2%

Prior period

USD 14,707

2010-03-01 – 2011-02-28
Current period

USD 94,745

2011-03-01 – 2012-02-29

Exact inputs and evidence

94745 − 14707 = 80038 USD

14707 USD · 2010-03-01 – 2011-02-28
Inspect prior input Prior source
94745 USD · 2011-03-01 – 2012-02-29
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOSTEM U.S. CORPORATION · 2012-02-29 BIOSTEM U.S. CORPORATION (edgar:1455380) Year-over-year change in Revenue: 80038 USD Concept: fundies:Revenue Period: 2011-03-01 to 2012-02-29 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 94745 USD (2011-03-01 to 2012-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#19953 Filing: 000147793212001877 Input fundies:Revenue: 14707 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#20067 Filing: 000147793212001877
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.16 million

Prior period

−USD 179,623

2010-03-01 – 2011-02-28
Current period

−USD 3.34 million

2011-03-01 – 2012-02-29

Exact inputs and evidence

-3337419 − -179623 = -3157796 USD

-179623 USD · 2010-03-01 – 2011-02-28
Inspect prior input Prior source
-3337419 USD · 2011-03-01 – 2012-02-29
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOSTEM U.S. CORPORATION · 2012-02-29 BIOSTEM U.S. CORPORATION (edgar:1455380) Year-over-year change in Net income: -3157796 USD Concept: fundies:NetIncome Period: 2011-03-01 to 2012-02-29 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -3337419 USD (2011-03-01 to 2012-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#21795 Filing: 000147793212001877 Input fundies:NetIncome: -179623 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#21922 Filing: 000147793212001877
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 550,170

Prior period

−USD 195,901

2010-03-01 – 2011-02-28
Current period

−USD 746,071

2011-03-01 – 2012-02-29

Exact inputs and evidence

-746071 − -195901 = -550170 USD

-195901 USD · 2010-03-01 – 2011-02-28
Inspect prior input Prior source
-746071 USD · 2011-03-01 – 2012-02-29
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BIOSTEM U.S. CORPORATION · 2012-02-29 BIOSTEM U.S. CORPORATION (edgar:1455380) Year-over-year change in Operating cash flow: -550170 USD Concept: fundies:OperatingCashFlow Period: 2011-03-01 to 2012-02-29 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -746071 USD (2011-03-01 to 2012-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#23078 Filing: 000147793212001877 Input fundies:OperatingCashFlow: -195901 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#23262 Filing: 000147793212001877
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2012 2011-03-01 – 2012-02-29

Revenue USD 94,745 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −USD 3.34 million −3,523% of revenue

Cash

Operating cash flow −USD 746,071 −787% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Not shown: operating income or net income is not reported.
2011 Operating loss: operating costs were 1,321% of revenue.
2012 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2009-03-01 – 2010-02-28	0	26801 Derived	-26801	-1117 Derived	-25684	Unavailable	Source 2009-03-01 – 2010-02-28: 0 USD Inspect Revenue Open source 2009-03-01 – 2010-02-28: -26801 USD Inspect Operating Income Open source 2009-03-01 – 2010-02-28: -25684 USD Inspect Net Income Open source 2009-03-01 – 2010-02-28: -15684 USD Inspect Operating Cash Flow Open source
2011 2010-03-01 – 2011-02-28	14707	194330 Derived	-179623	0 Derived	-179623	Unavailable	Source 2010-03-01 – 2011-02-28: 14707 USD Inspect Revenue Open source 2010-03-01 – 2011-02-28: -179623 USD Inspect Operating Income Open source 2010-03-01 – 2011-02-28: -179623 USD Inspect Net Income Open source 2010-03-01 – 2011-02-28: -195901 USD Inspect Operating Cash Flow Open source
2012 2011-03-01 – 2012-02-29	94745	Unavailable	Unavailable	Unavailable	-3337419	Unavailable	Source 2011-03-01 – 2012-02-29: 94745 USD Inspect Revenue Open source 2011-03-01 – 2012-02-29: -3337419 USD Inspect Net Income Open source 2011-03-01 – 2012-02-29: -746071 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 94.7K 2012

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-02-28	Revenue	0	Revenue: 0 Open source
20112011-02-28	Revenue	14707	Revenue: 14707 Open source
20122012-02-29	Revenue	94745	Revenue: 94745 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

544.2% 2012

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Year over year	No prior comparable period	Revenue: 0 Open source
20112011-02-28	Year over year	No prior comparable period	Revenue: 14707 Open source Revenue: 0 Open source
20122012-02-29	Year over year	544.2%	Revenue: 94745 Open source Revenue: 14707 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,221.3% 2011

Net margin -3,522.5% 2012

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Operating margin	Not reported	Operating Income: -26801 Open source Revenue: 0 Open source
20112011-02-28	Operating margin	-1,221.3%	Operating Income: -179623 Open source Revenue: 14707 Open source
2012-02-29	Operating margin	Not reported	Revenue: 94745 Open source
20102010-02-28	Net margin	Not reported	Net Income: -25684 Open source Revenue: 0 Open source
20112011-02-28	Net margin	-1,221.3%	Net Income: -179623 Open source Revenue: 14707 Open source
20122012-02-29	Net margin	-3,522.5%	Net Income: -3337419 Open source Revenue: 94745 Open source
20102010-02-28	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -15684 Open source
20112011-02-28	Free cash flow margin	Not reported	Revenue: 14707 Open source Operating Cash Flow: -195901 Open source
20122012-02-29	Free cash flow margin	Not reported	Revenue: 94745 Open source Operating Cash Flow: -746071 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -746.1K 2012

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-02-28	Operating cash flow	-15684	Operating Cash Flow: -15684 Open source
20112011-02-28	Operating cash flow	-195901	Operating Cash Flow: -195901 Open source
20122012-02-29	Operating cash flow	-746071	Operating Cash Flow: -746071 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-02-28	Free cash flow	Unavailable	Operating Cash Flow: -15684 Open source
20112011-02-28	Free cash flow	Unavailable	Operating Cash Flow: -195901 Open source
20122012-02-29	Free cash flow	Unavailable	Operating Cash Flow: -746071 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

567.9% 2012

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Liabilities / assets	Not reported	Total Liabilities: 2396 Open source Total Assets: 0 Open source
20112011-02-28	Liabilities / assets	20%	Total Liabilities: 64365 Open source Total Assets: 322346 Open source
20122012-02-29	Liabilities / assets	567.9%	Total Liabilities: 90318 Open source Total Assets: 15904 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.18× 2012

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Current assets / current liabilities	0×	Current Assets: 0 Open source Current Liabilities: 2396 Open source
20112011-02-28	Current assets / current liabilities	4.84×	Current Assets: 311846 Open source Current Liabilities: 64365 Open source
20122012-02-29	Current assets / current liabilities	0.18×	Current Assets: 15904 Open source Current Liabilities: 90318 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2009-03-01 – 2010-02-28	−USD 25,684 Exact value Exact value: -25684 USD 2009-03-01 – 2010-02-28: -25684 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSTEM U.S. CORPORATION · 2010-02-28 BIOSTEM U.S. CORPORATION (edgar:1455380) Net Income: -25684 USD Concept: fundies:NetIncome Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380/explain?concept=fundies%3ANetIncome&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:NetIncome: -25684 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/0001354488-11-001755.txt#4083 The citation records this snapshot. The page link may show a newer release later.	−USD 15,684 Exact value Exact value: -15684 USD 2009-03-01 – 2010-02-28: -15684 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSTEM U.S. CORPORATION · 2010-02-28 BIOSTEM U.S. CORPORATION (edgar:1455380) Operating Cash Flow: -15684 USD Concept: fundies:OperatingCashFlow Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380/explain?concept=fundies%3AOperatingCashFlow&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15684 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/0001354488-11-001755.txt#4211 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2010-03-01 – 2011-02-28	−USD 179,623 Exact value Exact value: -179623 USD 2010-03-01 – 2011-02-28: -179623 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSTEM U.S. CORPORATION · 2011-02-28 BIOSTEM U.S. CORPORATION (edgar:1455380) Net Income: -179623 USD Concept: fundies:NetIncome Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380/explain?concept=fundies%3ANetIncome&period=2011-02-28&surface=latest&period_type=duration&start=2010-03-01&unit=USD&dimensions= Input fundies:NetIncome: -179623 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#21922 Filing: 000147793212001877 The citation records this snapshot. The page link may show a newer release later.	−USD 195,901 Exact value Exact value: -195901 USD 2010-03-01 – 2011-02-28: -195901 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSTEM U.S. CORPORATION · 2011-02-28 BIOSTEM U.S. CORPORATION (edgar:1455380) Operating Cash Flow: -195901 USD Concept: fundies:OperatingCashFlow Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380/explain?concept=fundies%3AOperatingCashFlow&period=2011-02-28&surface=latest&period_type=duration&start=2010-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -195901 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#23262 Filing: 000147793212001877 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2011-03-01 – 2012-02-29	−USD 3.34 million Exact value Exact value: -3337419 USD 2011-03-01 – 2012-02-29: -3337419 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOSTEM U.S. CORPORATION · 2012-02-29 BIOSTEM U.S. CORPORATION (edgar:1455380) Net Income: -3337419 USD Concept: fundies:NetIncome Period: 2011-03-01 to 2012-02-29 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380/explain?concept=fundies%3ANetIncome&period=2012-02-29&surface=latest&period_type=duration&start=2011-03-01&unit=USD&dimensions= Input fundies:NetIncome: -3337419 USD (2011-03-01 to 2012-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#21795 Filing: 000147793212001877 The citation records this snapshot. The page link may show a newer release later.	−USD 746,071 Exact value Exact value: -746071 USD 2011-03-01 – 2012-02-29: -746071 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BIOSTEM U.S. CORPORATION · 2012-02-29 BIOSTEM U.S. CORPORATION (edgar:1455380) Operating Cash Flow: -746071 USD Concept: fundies:OperatingCashFlow Period: 2011-03-01 to 2012-02-29 Values: Latest reported Published: 2026-11-04T17:57:15Z Snapshot: a3af77b8fc543972d4da6cf262689c00582f9c3260701f909b74cfefebfce505 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1455380/explain?concept=fundies%3AOperatingCashFlow&period=2012-02-29&surface=latest&period_type=duration&start=2011-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -746071 USD (2011-03-01 to 2012-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1455380/000147793212001877/bosm-20120229.xml#23078 Filing: 000147793212001877 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

20 filings · 307 latest values · 307 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001455380, 1455380, edgar:1455380

Also known as BIOSTEM U.S. CORP, BIOSTEM U.S. CORPORATION, Equinox International, Inc.

BIOSTEM U.S. CORPORATION

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2012 2011-03-01 – 2012-02-29

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation